The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study

BACKGROUND: Oseltamivir has been used as adjunctive therapy in the management of patients with COVID-19. However, the evidence about using oseltamivir in critically ill patients with severe COVID-19 remains scarce. This study aims to evaluate the effectiveness and safety of oseltamivir in critically...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljuhani, Ohoud, Korayem, Ghazwa B., Altebainawi, Ali F., Alotaibi, Meshal S., Alrakban, Noura A., Ghoneim, Ragia H., Vishwakarma, Ramesh, Al Shaya, Abdulrahman I., Al Harbi, Shmeylan, Gramish, Jawaher, Almutairi, Dahlia M., Alqannam, Ghada, Alamri, Faisal F., Alharthi, Abdullah F., Alfaifi, Mashael, Al Amer, Abdullah, Alenazi, Abeer A., Bin Aydan, Norah, Alalawi, Mai, Al Sulaiman, Khalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203981/
https://www.ncbi.nlm.nih.gov/pubmed/37256102
http://dx.doi.org/10.1016/j.jsps.2023.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203981/
https://www.ncbi.nlm.nih.gov/pubmed/37256102
http://dx.doi.org/10.1016/j.jsps.2023.05.006

Ejemplares similares